Skip to main content
NACFC 2025 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestreamed Session
Livestreamed Session

IMI
Session Type: Thematic Poster Session

TPS02--Models Systems to Study Pulmonary & Non-pulmonary Manifestations of CF

Thursday, October 23, 2025
12:30 PM - 2:00 PM PDT
Location:Theater A Exhibit Hall

This session will provide a quick description of the use of model systems, both in vitro and in vivo, for the study of pulmonary and non-pulmonary manifestations of CF.

Learning Objectives:

  • Evaluate the application of induced pluripotent stem cell (iPSC) models in studying gastrointestinal manifestations of cystic fibrosis (CF), including their utility in elucidating pathophysiological mechanisms and modeling patient-specific phenotypes
  • Explore novel in vivo models in evaluating the efficacy and mechanistic impact of CF-directed therapies including CFTR modulators and emerging mRNA-based treatments
  • Describe novel approaches to advance understanding and care of CF including developing mechanistic insights in cell type tracking, novel infectious disease therapeutics, and aging with CF

Presentations:

  • 12:30 PM - 2:00 PM PDT
    A CFTR mouse model to study nonsense mutations independent of nonsense-mediated decay.

    Speaker: Lisa Nicholson – Case Western Reserve University.

  • 12:30 PM - 2:00 PM PDT
    Modeling cystic fibrosis patient-specific responses to modulators using human induced pluripotent stem cells

    Speaker: Kayshani R. Kanagarajah – University of Toronto & The Hospital for Sick Children

  • 12:30 PM - 2:00 PM PDT
    Nitric oxide-releasing prodrug eradicates Pseudomonas aeruginosa and reduces inflammation in a mucus-producing rat model for cystic fibrosis

    Speaker: Mark H. Schoenfisch, PhD – University of North Carolina at Chapel Hill

  • 12:30 PM - 2:00 PM PDT
    ETI treatment extends the lifespan of CFTR-F508del rabbits

    Speaker: Yang Liu, n/a – University of Michigan

  • 12:30 PM - 2:00 PM PDT
    Increased small airway clearance after starting highly effective modulator therapy: Decoding "the purge" in cystic fibrosis

    Speaker: Brie M. Hilkin, BS – University of Iowa

  • 12:30 PM - 2:00 PM PDT
    Efficient mRNA delivery to the ferret lung using Selectivity Enabling Nanoshell (SENS™)

    Speaker: Weam S A Shahin, MD PhD – University of Iowa

  • 12:30 PM - 2:00 PM PDT
    Cystic Fibrosis-related neurodegenerative disease associated with tauopathy and cognitive decline in aged CF mice

    Speaker: Danica Parfyonov, PhD – Case Western Reserve University

  • 12:30 PM - 2:00 PM PDT
    Development of iPSC reporter lines to track ionocyte specification and maturation

    Speaker: Ruth-Love Damoah, n/a

  • 12:30 PM - 2:00 PM PDT
    iPSC-derived human intestinal organoids model gastrointestinal manifestations of Cystic Fibrosis

    Speaker: Heather A. McCauley, PhD – University of North Carolina at Chapel Hill

  • 12:30 PM - 2:00 PM PDT
    Understanding the role of CFTR in pancreatic progenitor development to target exocrine pancreatic insufficiency 

    Speaker: Amy L. Ryan – University of Iowa